0001363585-12-000010.txt : 20120627
0001363585-12-000010.hdr.sgml : 20120627
20120627160937
ACCESSION NUMBER: 0001363585-12-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120625
FILED AS OF DATE: 20120627
DATE AS OF CHANGE: 20120627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FELLOWS STEPHEN
CENTRAL INDEX KEY: 0001363585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 12929636
MAIL ADDRESS:
STREET 1: C/O SONA MOBILE HOLDINGS CORP
STREET 2: 825 THIRD AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J 2G2
BUSINESS PHONE: 4163642551
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CA
STATE: A1
ZIP: M5J 2G2
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0305
4
2012-06-25
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001363585
FELLOWS STEPHEN
33 HARBOUR SQUARE
SUITE 202
TORONTO
A6
M5J 2G2
ONTARIO, CANADA
0
1
0
0
Acting Chief Financial Officer
Common Stock
2012-06-25
4
S
0
546448
0.0922
D
0
D
The shares sold were acquired by the reporting person on June 21, 2012 upon exercise of options to purchase 546,448 shares of the issuer's common stock, which were granted by the Board of Directors on June 6, 2012 in lieu of cash payment of deferred compensation. The option grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer on June 20, 2012 and was made pursuant to the terms of the issuer's 2006 stock plan.
Stephen Fellows
2012-06-27